SEC Form 4 · accession 0001144204-18-008232
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Lee Miller
Officer — Chief Operating Officer
Period of report
Feb 9, 2018
Accepted (ET)
Feb 13, 2018 · 9:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Feb 9, 2018 | M | 8,582 | $11.83 | A | 8,582 | D | |
| Class A Common StockF2 | Feb 9, 2018 | S | 8,582 | $35.36 | D | 0 | D | |
| Class A Common Stock | Feb 9, 2018 | M | 5,600 | $11.83 | A | 5,600 | D | |
| Class A Common StockF3 | Feb 9, 2018 | S | 5,600 | $35.69 | D | 0 | D | |
| Class A Common Stock | Feb 12, 2018 | M | 17,804 | $11.83 | A | 17,804 | D | |
| Class A Common StockF4 | Feb 12, 2018 | S | 17,804 | $35.61 | D | 0 | D | |
| Class A Common Stock | Feb 12, 2018 | M | 500 | $11.83 | A | 500 | D | |
| Class A Common StockF5 | Feb 12, 2018 | S | 500 | $36.22 | D | 0 | D | |
| Class A Common Stock | Feb 13, 2018 | M | 22,086 | $11.83 | A | 22,086 | D | |
| Class A Common StockF6 | Feb 13, 2018 | S | 22,086 | $35.05 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Feb 9, 2018 | M | 14,182 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 14,182 | 58,318 | D |
| Option to purchase Common Stock | $11.83 | Feb 12, 2018 | M | 18,304 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 18,304 | 40,014 | D |
| Option to purchase Common Stock | $11.83 | Feb 13, 2018 | M | 22,086 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 22,086 | 17,928 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.60, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.65 to $35.90, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.15 to $36.00, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.18 to $36.40, inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.75 to $35.40, inclusive.